Clinical and biological characteristics of the patients
| Characteristic . | No. (total) . | % . | Range . |
|---|---|---|---|
| Sex | |||
| Male | 4 | ||
| Female | 11 | ||
| Age at diagnosis, y | 44 | 29-57 | |
| Tobacco use | 100 | ||
| Lymphocyte count ×109/L | 6 | 3.2-14.5 | |
| Lymphocyte count, % of leukocytes | 49 | 30-77 | |
| Binucleated lymphocytes | 5 | 2-11 | |
| Splenomegaly | 3/13 | 23 | |
| Increased polyclonal immunoglobulin M | 10/10 | 100 | |
| HLA-DR7 | 7/12 | 58 | |
| Cytogenetic abnormalities | 10/15 | 67 | |
| +I3q | 8/15 | 53 | |
| Lymphoma evolution | 1/15 | 6.7 |
| Characteristic . | No. (total) . | % . | Range . |
|---|---|---|---|
| Sex | |||
| Male | 4 | ||
| Female | 11 | ||
| Age at diagnosis, y | 44 | 29-57 | |
| Tobacco use | 100 | ||
| Lymphocyte count ×109/L | 6 | 3.2-14.5 | |
| Lymphocyte count, % of leukocytes | 49 | 30-77 | |
| Binucleated lymphocytes | 5 | 2-11 | |
| Splenomegaly | 3/13 | 23 | |
| Increased polyclonal immunoglobulin M | 10/10 | 100 | |
| HLA-DR7 | 7/12 | 58 | |
| Cytogenetic abnormalities | 10/15 | 67 | |
| +I3q | 8/15 | 53 | |
| Lymphoma evolution | 1/15 | 6.7 |